All Updates

All Updates

icon
Filter
M&A
Labcorp acquires Ivitae's select assets for USD 239 million
Precision Medicine
Apr 24, 2024
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Product updates
Uber releases five new features for holiday travel season
Travel Tech
Yesterday
Precision Medicine

Precision Medicine

Apr 24, 2024

Labcorp acquires Ivitae's select assets for USD 239 million

M&A

  • Labcorp has been selected as the winning bidder of select assets of Invitae for a sum of USD 239 million. The transaction is expected to be closed in the third quarter of 2024 after the regulatory approval, following a court hearing currently scheduled for May 6.

  • Through this transaction, Labcorp would acquire Invitae’s assets, which would be auctioned through a voluntary bankruptcy protection process. Post-acquisition, Labcorp intends to harness Invitae's assets to scale its specialty testing in areas like oncology and rare diseases. This acquisition is expected to generate annual revenue of approximately USD 275 million–300 million for Labcorp, most of which will come from specialty testing.

  • Labcorp, a subsidiary of Laboratory Corporation of America Holdings, is a life sciences healthcare company that provides services in diagnostics, drug development and manufacturing, research and analysis, drug safety testing, and clinical trials.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.